Anderson J P, Williams B T, Hughes D C. "一种的合成方法" [P]. US Patent, US 9484506 B2, 2023-07-07.
Jørgensen K, Johansson L, Mueller T C. "Method for the Synthesis of 2-Methyl-3-(1,3,4-oxadiazol-2-yl)aniline" [P]. European Patent, EP 3764016 A1, 2020-02-17.
Lee S K, Roberts E F, Park J H. "A Process for Preparing High-Purity 2-Methyl-3-(1,3,4-oxadiazol-2-yl)aniline" [P]. US Patent, US 9648979 B2, 2021-04-22.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Molecules, 2016, 711, 7201-7218.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chim. Acta, 2013, 918, 1097-1101.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of 2-Methyl-3-(1,3,4-oxadiazol-2-yl)aniline Using HRMS and NMR". Anal. Chem., 2010, 1078, (12), 3889-3910.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2010, 496, 4540-4546.